U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
SINTILIMAB
8FU7FQ8UPK
Investigational
General
Names
8
Classification
4
Identifiers
6
Subunits
4
Related Substances
1
SINTILIMAB
8FU7FQ8UPK
Investigational
General
Approval Year
Unknown
139,594
Names
8
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SINTILIMAB
Official Name
English
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL IBI308 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI308 .KAPPA.-CHAIN, DIMER
Common Name
English
Sintilimab [WHO-DD]
Common Name
English
IBI-308
Code
English
IBI308
Code
English
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Classification
4
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Antineoplastic Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Antineoplastic Biological Agent
[C129821]
Antineoplastic Antibody
NCI_THESAURUS
C129822
Designated
ORPHAN DRUG
Designated
Treatment of T-cell lymphoma
FDA ORPHAN DRUG
733120
Designated
ORPHAN DRUG
Designated
Treatment of esophageal cancer
FDA ORPHAN DRUG
737320
Monoclonal Antibody
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
[C20401]
Anti-PD1 Monoclonal Antibody
NCI_THESAURUS
C128037
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
FDA UNII
8FU7FQ8UPK
PRIMARY
INN
10801
PRIMARY
USAN
JK-94
PRIMARY
NCI_THESAURUS
C132992
PRIMARY
WIKIPEDIA
Sintilimab
PRIMARY
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
8FU7FQ8UPK
SINTILIMAB